US20030163054A1 - Monitoring respiration based on plethysmographic heart rate signal - Google Patents
Monitoring respiration based on plethysmographic heart rate signal Download PDFInfo
- Publication number
- US20030163054A1 US20030163054A1 US10/081,719 US8171902A US2003163054A1 US 20030163054 A1 US20030163054 A1 US 20030163054A1 US 8171902 A US8171902 A US 8171902A US 2003163054 A1 US2003163054 A1 US 2003163054A1
- Authority
- US
- United States
- Prior art keywords
- signal
- heart rate
- patient
- pleth
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000029058 respiratory gaseous exchange Effects 0.000 title claims abstract description 62
- 238000012544 monitoring process Methods 0.000 title claims abstract description 23
- 238000012545 processing Methods 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 26
- 239000008280 blood Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 17
- 230000003287 optical effect Effects 0.000 claims description 13
- 230000003993 interaction Effects 0.000 claims description 6
- 230000003595 spectral effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010183 spectrum analysis Methods 0.000 claims 2
- 230000002452 interceptive effect Effects 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 5
- 238000001228 spectrum Methods 0.000 description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 230000000241 respiratory effect Effects 0.000 description 8
- 230000003044 adaptive effect Effects 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000002596 correlated effect Effects 0.000 description 4
- 230000000541 pulsatile effect Effects 0.000 description 4
- 230000001457 vasomotor Effects 0.000 description 4
- 238000006213 oxygenation reaction Methods 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 206010061666 Autonomic neuropathy Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 2
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 238000013186 photoplethysmography Methods 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 206010047302 ventricular tachycardia Diseases 0.000 description 2
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000005574 cross-species transmission Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000492 nasalseptum Anatomy 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012776 robust process Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000004148 unit process Methods 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
Definitions
- the present invention relates, in general, to the noninvasive monitoring of respiration rate based on optical (visible and/or non-visible spectrum) signals and, in particular, to monitoring respiration based on the processing of received optical signals to identify heart rate variability associated with respiration.
- the invention can be readily implemented in connection with pulse oximetry instruments so as to expand the utility of such instruments.
- Photoplethysmography relates to the use of optical signals transmitted through or reflected by a patient's blood, e.g., arterial blood or perfused tissue, for monitoring a physiological parameter of a patient.
- a patient's blood e.g., arterial blood or perfused tissue
- Such monitoring is possible because the optical signal is modulated by interaction with the patient's blood. That is, interaction with the patient's blood generally involving a wavelength and/or time dependent attenuation due to absorption, reflection and/or diffusion, imparts characteristics to the transmitted signal that can be analyzed to yield information regarding the physiological parameter of interest.
- Such monitoring of patients is highly desirable because it is noninvasive, typically yields substantially instantaneous and accurate results, and utilizes minimal medical resources, thereby proving to be cost effective.
- Pulse oximeters determine an oxygen saturation level of a patient's blood, or related analyte values, based on transmission/absorption characteristics of light transmitted through or reflected from the patient's tissue.
- pulse oximeters generally include a probe for attaching to a patient's appendage such as a finger, earlobe or nasal septum.
- the probe is used to transmit pulsed optical signals of at least two wavelengths, typically red and infrared, through the patient's appendage.
- the transmitted signals are received by a detector that provides an analog electrical output signal representative of the received optical signals.
- A/D analog to digital
- a single multi-channel digital signal may be received by the digital processing unit or separate digital signals for each channel may be received.
- the digital processing unit may be used to separate the received signal into separate channel components.
- the digital processing unit processes digital information representing each of the channels.
- Such digital information defines input photoplethysmographic signals or “pleths.” These pleths generally contain two components.
- the first component of interest is a low frequency or substantially invariant component in relation to the time increments considered for blood oxygen saturation calculations, sometimes termed the “DC component,” which generally corresponds to the attenuation related to the non-pulsatile volume of the perfused tissue and other matter that affects the transmitted plethysmographic signal.
- the second component sometimes termed the “AC component” generally corresponds to the change in attenuation due to the pulsation of the blood.
- the AC component represents a varying waveform which corresponds in frequency to that of the heartbeat.
- the DC component is a more steady baseline component, since the effective volume of the tissue under investigation varies little or at a low frequency if the variations caused by the pulsation of the heart are excluded from consideration.
- Pulse oximeters typically provide as outputs blood oxygen saturation values and, sometimes, a heart rate and a graphical representation of a pulsatile waveform.
- the information for generating each of these outputs is generally obtained from the AC component of the pleth.
- some pulse oximeters attempt to filter the DC component from the pleth, e.g., in order to provide a better digitized AC component waveform.
- Other pulse oximeters may measure and use the DC component, e.g., to normalize measured differential values obtained from the AC component or to provide measurements relevant to motion or other noise corrections.
- the present invention is directed to monitoring patient respiration based on a pleth signal.
- the invention thus provides important diagnostic or monitoring information noninvasively.
- various aspects of the invention can be implemented using one or more channels and/or other components of a conventional pulse oximeter, thereby providing additional functionality to instruments that are widely available and trusted, as well as providing access to important information for treatment of patients on a cost-effective basis.
- a pleth signal is analyzed to identify a heart rate variability parameter associated with respiration rate.
- the associated process involves obtaining a pleth signal, processing the pleth signal to obtain heart rate samples, monitoring the heart rate samples to identify a heart rate variability, and determining a respiration rate based on the heart rate variability. It is known that heart rate varies with the respiration cycle, an effect called Respiratory Sinus Arrhythmia.
- the present invention provides a robust process for monitoring this effect and determining respiration rate based on pleth signals.
- a novel processor and pulse oximeter incorporating such processing are also provided in accordance with the present invention.
- the step of obtaining a pleth signal generally involves receiving a digital signal representative of an optical signal modulated based on interaction with perfused tissue of a patient.
- a digital signal representative of an optical signal modulated based on interaction with perfused tissue of a patient.
- Such a signal may be provided using components of a conventional pulse oximeter.
- Pulse oximeters typically transmit red and infrared signals, thereby yielding red and infrared pleths.
- each of these pleths generally has a fundamental frequency corresponding to the patient's heart rate. Accordingly, either pleth can be used to yield the desired heart rate information.
- the infrared channel typically has the stronger pleth waveform and may be preferred for heart rate calculations.
- the red pleth may be preferred.
- a combination of the two signals may provide a better waveform for heart rate analysis than either signal alone.
- the pleth may be processed to obtain heart rate samples in a variety of ways.
- the pleth is generally a periodic signal having a fundamental frequency corresponding to the patient's heart rate.
- heart rate may be determined by performing peak-to-peak measurements on the pleth to determine the pulse period and, hence, pulse frequency. For example, such maxima may be obtained by identifying a change in sign of differential values between successive samples or groups of samples along the pleth or of a function fitted to the pleth.
- other points on the waveform, such as nominal zero (or average pleth value) crossings may be monitored. Such zero crossings would be expected to have a frequency of twice the heart rate.
- Such period measurements can be complicated due to the typically noisy waveform of the pleths. Accordingly, multiple waveforms may be utilized.
- the heart rate calculations may be performed in the frequency domain.
- a processor may be configured to obtain a Fourier transform of the pleth. Once the Fourier transform is obtained, the pulse rate can be identified as the fundamental frequency of the pleth corresponding to the patient's heart rate.
- the heart rate once the heart rate is determined, it can be monitored to identify low frequency variations associated with respiration. In particular, oscillatory variations having a frequency of between about 0.15 and 0.5 Hz and, especially, between about 0.2 and 0.4 Hz, are indicative of respiration rate. This range may be expanded to 0-5 Hz to accommodate the higher respiration rates of newborns.
- One or more filters may be used in determining respiration rate information based on a pleth signal in accordance with the present invention.
- an adaptive filter may be used to track the fundamental frequency of the pleth and, hence, the patient's pulse rate.
- a filter may function as a narrow band pass filter having a band pass that is centered on the fundamental frequency of the pleth.
- the transfer function of the filter may be varied, e.g., based on analysis of successive waveforms, to track the changing fundamental frequency.
- the filter or associated logic may thus be adapted to output a time series of pulse rate values.
- Such a time series of pulse rate values may be filtered using a static band pass filter having a pass band including the noted frequencies of interest, or using an adaptive filter that tracks a selected spectral peak of the time series to provide an output indicative of respiration rate.
- a static band pass filter having a pass band including the noted frequencies of interest
- an adaptive filter that tracks a selected spectral peak of the time series to provide an output indicative of respiration rate.
- the present invention is based in part on a recognition that the pleth signal includes a variety of information in addition to the pulsatile waveform that is generally the focus of plethysmographic processing.
- the pleth signal includes at least three additional or related components: 1) a component related to respiration or the “respiration wave”, 2) a low frequency component associated with the autonomic nervous system or vaso motor center, sometimes termed the “Mayer wave,” and 3) a very low frequency component which is associated with temperature control.
- the Mayer wave relates to a low frequency variation in blood pressure, heart rate, and/or vaso constriction.
- the first two components noted above have particular significance for diagnostic and patient monitoring purposes.
- the amplitude and frequency of the Mayer wave are seen to change in connection with hypertension, sudden cardiac death, ventricular tachycardia, coronary artery disease, myocardial infarction, heart failure, diabetes, and autonomic neuropathy and after heart transplantation.
- Respiration rate is monitored during a variety of medical procedures, for example, as an indication of a patient's stress levels and to identify patient respiratory distress. It is expected that both the Mayer and respiration waves influence heart rate (and related parameters such as variations in blood pressure and blood volume) by direct influence on the vaso motor center. In the latter case, this is by a “spillover” from the breathing center to the vaso motor center, which increases heart rate during inspiration.
- a difficulty associated with obtaining physiological parameter information based on the Mayer wave and the respiration wave relates to distinguishing the effects associated with these waves, particularly in view of the fact that each of these waves can occur within overlapping frequency ranges.
- respiration information is obtained by monitoring heart rate variability within a specific frequency band as noted above.
- a frequency range having a lower end of preferably at least about 0.15 Hz, for example, 0.15-0.5 interference due to Mayer wave effects can generally be minimized.
- Still better results may be obtained by monitoring a range between about 0.2-0.4 Hz or, especially, about 0.3 Hz.
- the transfer function may be limited to track the respiration related peak only within these ranges using 0.3 Hz as an initial condition.
- FIG. 1 is a schematic diagram of a pulse oximeter in accordance with the present invention
- FIG. 2 illustrates the waveform of a pleth that may be used to obtain respiratory information in accordance with the present invention
- FIG. 3 illustrates a pleth power spectrum showing the respiration related peak that is used in accordance with the present invention
- FIG. 4 illustrates a heart rate time series generated using an appropriate filter in accordance with the present invention
- FIG. 5 is a pleth power spectrum illustrating a transfer function of a filter in accordance with the present invention
- FIG. 6 is a respiratory power spectrum illustrating a transfer function of another filter in accordance with the present invention.
- FIG. 7 is a flow chart illustrating a process for using a pleth signal to monitor respiration in accordance with the present invention.
- FIG. 8 illustrates a signal processing system in accordance with the present invention.
- the present invention relates to obtaining physiological parameter information for a patient based on an analysis of a pleth involving distinguishing an effect associated with a Mayer wave component from an effect associated with a respiration wave component.
- the invention is described in the context of an implementation utilizing components of a conventional pulse oximeter.
- the invention has particular advantages in this regard as such an implementation enhances the functionality of conventional pulse oximeters and provides important physiological parameter information in a cost effective manner.
- various aspects of the invention are not limited to such a pulse oximeter or other multi-channel signal implementation and the invention may be embodied in a dedicated single or multi-channel photoplethysmography instrument. Accordingly, the following discussion should be understood as exemplifying the invention and not by way of limitation.
- the oximeter 100 generally includes an instrument housing 102 and a probe 104 for attachment to a finger 101 or other appendage of a patient under analysis.
- the probe 104 includes two or more sources 106 and a detector 110 . It will be appreciated that either or both of these components may alternatively be located in the housing 102 and may be optically connected to the probe 104 by fiber optics or the like. Additionally, the sources 106 and/or detector 110 may be located in the cable or other coupling operatively between the probe 104 and the housing 102 .
- the sources 106 are driven by source drives 108 .
- the drives 108 serve to modulate the signals 103 in any of various ways.
- the signals 103 transmitted by the sources 106 may be time division multiplexed, frequency division multiplexed, code division multiplexed, or the like. Such multiplexing facilitates separation of the signals from each of the channels during hardware or software based signal processing.
- the sources 106 provide two or more channels of signals 103 . Each channel has a unique spectral content, e.g., wavelength or wavelength band. In the illustrated embodiment, two sources 106 are shown; one of the sources may have a red-centered wavelength and the other may have an infrared-centered wavelength.
- the signals 103 may be transmitted through or reflected by the patient's tissue. In either case, the signals are modulated by the patient's tissue to provide information regarding blood oxygen saturation in a manner that is well known.
- the transmitted signals 103 are received by the detector 110 which, in the illustrated embodiment, provides an analog current output signal 105 representative of the detected signals 103 .
- This detector signal 105 is then processed by signal processing module 112 .
- the processing module 112 may include a number of components that may be embodied in software, firmware and/or hardware. These components may include components for amplifying the signal 105 and converting the signal from a current signal to a voltage signal, filtering the signal to remove certain components of noise and otherwise conditioning the signal.
- the signal processing module 112 also includes an analog to digital converter for converting the signal into a digital signal and a demultiplexer component for providing two separate output signals 118 or pleths that generally correspond to the two separate channel signals 103 . These pleths 118 are then used by oxygenation calculation module 116 to compute a value related to blood oxygen saturation, e.g., a blood oxygen saturation percentage.
- a blood oxygen saturation percentage e.g., a blood oxygen saturation percentage.
- FIG. 2 illustrates an exemplary waveform of a pleth as such information may be obtained by the processor of a pulse oximeter.
- information may be obtained as a digital signal output by the A/D converter, i.e., a time series of values related to the detector output.
- the pleth corresponding to either of the oximetry channels, or a combination of the channels, may be used in accordance with the present invention. It is desirable to obtain a strong pleth signal so that the waveform and pulse rate can be accurately identified. Accordingly, for normally oxygenated patients, the infrared channel pleth may be utilized. For poorly oxygenated patients, the red pleth may be preferred.
- a cut off oxygenation level such as 85% may be used in determining whether to use the infrared or red pleth.
- the two pleth signals may be mathematically blended, depending on the current oxygenation level to obtain an optimized pleth for subsequent analysis in accordance with the present invention.
- Appropriate techniques for obtaining an optimized pleth signal are disclosed in U.S. patent application Ser. No. 09/975,289, which is disclosed herein by reference.
- the pleth signal includes a pulsatile component having a period designated T p .
- This period corresponds to the patient's heart rate.
- the heart rate can be determined by monitoring this pleth in a variety of ways such as identifying a change in sign of a differential value of the waveform (e.g., to perform a peak-to-peak period measurement or peak-to-trough 1 ⁇ 2 period measurement), tracking crossings of an average value indicated by A, or, as will be discussed in more detail below, by using a filter to track the fundamental frequency of the pleth.
- FIG. 3 shows an exemplary pleth power spectrum.
- the spectrum is characterized by three discrete peaks. These include a peak typically around 0.3 Hz-0.5 Hz, a peak typically around 0.1 Hz and a peak below 0.05 Hz.
- the peak below 0.05 Hz is generally linked with vaso motor control and temperature control.
- the peak at around 0.1 Hz is generally associated with the Mayer wave.
- this phenomenon is not well understood but has been correlated to hypertension, sudden cardiac death, ventricular tachycardia, coronary artery disease, myocardial infarction, heart failure, diabetes, and autonomic neuropathy and has been seen to change after heart transplantation.
- the remaining peak, at about 0.3-0.5 Hz is believed to be correlated with respiration and is of particular interest for purposes of the present invention. It will be appreciated that this peak may be as high as 1 Hz or greater for newborns.
- FIG. 4 graphically illustrates the respiratory Sinus Arrhythmia phenomenon associated with the above noted respiration wave.
- FIG. 4 is a graph plotting the output of a heart rate filter, as will be discussed below, against time.
- the result is a periodic waveform having a period designated T B .
- T B This generally corresponds to a reduction in heart rate during the expiration portion of the respiratory cycle and an increase in heart rate during the inspiration portion of the cycle.
- the period of this waveform generally corresponds to the respiration rate and is tracked using a pulse oximeter in accordance with the present invention.
- respiration rate can be monitored by: 1) determining heart rate based on an analysis of the pleth signal, 2) monitoring this heart rate over time to obtain a time series heart rate values, and 3) analyzing the time series heart rate values to identify a respiration rate. These steps can be executed using adaptive filters and/or static band pass filters as discussed below.
- FIG. 5 illustrates a pleth power spectrum.
- a power spectrum may be obtained by configuring the oximeter processor to mathematically obtain a Fourier transform of the time domain pleth signal.
- the pleth power spectrum has a fundamental frequency at t 0 corresponding to the patient's heart rate. Additional peaks of the illustrated power spectrum relate to harmonics thereof.
- the present invention utilizes an adaptive filter adapted to function as a band pass filter having a narrow band pass encompassing the fundamental frequency. The transfer function of this filter is generally indicated by function 500 .
- a variety of different types of filters may be used in this regard. Generally, such filters track the fundamental frequency of a signal based on certain programmed information regarding the nature of the signal as well as by monitoring successive signal waveforms. Such filters are robust in operation and can provide a continually updated output, in this case, regarding pulse rate. Thus, such a filter can provide as an output a time series of pulse rate values such as illustrated in FIG. 4.
- An additional digital filter can be used to track respiration rate.
- the output of the heart rate filter can be processed to provide a respiratory power spectrum as shown in FIG. 6.
- the oximeter processor can be configured to perform a Fourier transform on the time series of pulse rate values output by the heart rate filter.
- the resulting respiratory power spectrum includes a frequency peak correlated to the respiration rate designated as t 0 .
- the additional peaks shown in the power spectrum of FIG. 6 relate to harmonics thereof or other heart rate variations.
- An adaptive filter having a transfer function, generally indicated by function 600 can be used to track the fundamental frequency.
- Such a filter may be similar to the heart rate filter as described above and is programmed to adaptively track the noted frequency of the respiratory power spectrum which corresponds to respiration rate.
- the output of this filter is a periodically updated respiration rate value.
- a static band pass filter may be used to isolate the peak related to respiration and, hence, identify the respiration rate.
- Such a filter may have a pass band of 0-0.5 Hz or, to accommodate neonatal applications, 0-1.5 Hz.
- FIG. 7 is a flow chart illustrating a process for determining respiration rate based on pleth signals in accordance with the present invention.
- the process 700 is initiated by obtaining a detector output or pleth signal. In the context of a pulse oximeter, this may involve receiving the digital output from an A/D converter that reflects the detector signal, demodulating this signal to obtain individual channel components and selecting a pleth for further processing.
- the selected pleth may be one of the channels or an optimized pleth based on both of the channel components.
- the pleth is then filtered ( 704 ) to obtain a time series of heart rate values. These values are monitored ( 706 ) over time to obtain a heart rate signal.
- the heart rate signal is then filtered ( 708 ) to identify a frequency peak correlated to respiration.
- the frequency of this peak is then output ( 710 ) as a respiration rate.
- This respiration rate may be displayed in the display area of a conventional pulse oximeter programmed to provide such information.
- the illustrative unit 800 includes an A/D converter 802 .
- the A/D converter receives an analog signal representative of the optical signal received by the pulse oximeter detector. This analog input signal is processed by the converter ( 802 ) to provide a digital detector signal 803 .
- the digital detector signal 803 is then processed by demodulator 804 to provide two separate channel signals designated channel A ( 805 ) and channel B ( 807 ), that may correspond, for example, to the red and infrared channels of the pulse oximeter. These channel signals are then processed by the optimized pleth generator 806 to provide an optimized pleth waveform 809 .
- the optimized pleth waveform may correspond to either of the channel signals or a combination thereof.
- This optimized waveform 809 is processed by a heart rate filter in order to track the fundamental frequency of the waveform which corresponds to the patient's heart rate.
- the output from the heart rate filter 808 is a time series of heart rate values 811 .
- This time series heart rate values is then processed by a respiration rate filter 810 which tracks a selected frequency of the corresponding spectrum to determine respiration rate 813 .
- the patient's respiration rate 813 may be periodically output to a user via a display 812 .
Abstract
Description
- The present invention relates, in general, to the noninvasive monitoring of respiration rate based on optical (visible and/or non-visible spectrum) signals and, in particular, to monitoring respiration based on the processing of received optical signals to identify heart rate variability associated with respiration. The invention can be readily implemented in connection with pulse oximetry instruments so as to expand the utility of such instruments.
- Photoplethysmography relates to the use of optical signals transmitted through or reflected by a patient's blood, e.g., arterial blood or perfused tissue, for monitoring a physiological parameter of a patient. Such monitoring is possible because the optical signal is modulated by interaction with the patient's blood. That is, interaction with the patient's blood generally involving a wavelength and/or time dependent attenuation due to absorption, reflection and/or diffusion, imparts characteristics to the transmitted signal that can be analyzed to yield information regarding the physiological parameter of interest. Such monitoring of patients is highly desirable because it is noninvasive, typically yields substantially instantaneous and accurate results, and utilizes minimal medical resources, thereby proving to be cost effective.
- A common type of photoplethysmographic instrument is the pulse oximeter. Pulse oximeters determine an oxygen saturation level of a patient's blood, or related analyte values, based on transmission/absorption characteristics of light transmitted through or reflected from the patient's tissue. In particular, pulse oximeters generally include a probe for attaching to a patient's appendage such as a finger, earlobe or nasal septum. The probe is used to transmit pulsed optical signals of at least two wavelengths, typically red and infrared, through the patient's appendage. The transmitted signals are received by a detector that provides an analog electrical output signal representative of the received optical signals. By processing the electrical signal and analyzing signal values for each of the wavelengths at different portions of a patient's pulse cycle, information can be obtained regarding blood oxygen saturation.
- The algorithms for determining blood oxygen saturation related values are normally implemented in a digital processing unit. Accordingly, one or more analog to digital (A/D) converters are generally interposed between the detector and the digital processing unit. Depending on the specific system architecture employed, a single multi-channel digital signal may be received by the digital processing unit or separate digital signals for each channel may be received. In the former case, the digital processing unit may be used to separate the received signal into separate channel components. Thus, in either case, the digital processing unit processes digital information representing each of the channels.
- Such digital information defines input photoplethysmographic signals or “pleths.” These pleths generally contain two components. The first component of interest is a low frequency or substantially invariant component in relation to the time increments considered for blood oxygen saturation calculations, sometimes termed the “DC component,” which generally corresponds to the attenuation related to the non-pulsatile volume of the perfused tissue and other matter that affects the transmitted plethysmographic signal. The second component, sometimes termed the “AC component,” generally corresponds to the change in attenuation due to the pulsation of the blood. In general, the AC component represents a varying waveform which corresponds in frequency to that of the heartbeat. In contrast, the DC component is a more steady baseline component, since the effective volume of the tissue under investigation varies little or at a low frequency if the variations caused by the pulsation of the heart are excluded from consideration.
- Pulse oximeters typically provide as outputs blood oxygen saturation values and, sometimes, a heart rate and a graphical representation of a pulsatile waveform. The information for generating each of these outputs is generally obtained from the AC component of the pleth. In this regard, some pulse oximeters attempt to filter the DC component from the pleth, e.g., in order to provide a better digitized AC component waveform. Other pulse oximeters may measure and use the DC component, e.g., to normalize measured differential values obtained from the AC component or to provide measurements relevant to motion or other noise corrections. Generally, though, conventional pulse oximeters do not monitor variations in the DC component of a pleth or pleths to obtain physiological parameter information in addition to the outputs noted above. Although it has been proposed to use pulse oximeters to monitor other parameters including respiration rate, it is apparent that such proposed uses have not gained general commercial acceptance.
- The present invention is directed to monitoring patient respiration based on a pleth signal. The invention thus provides important diagnostic or monitoring information noninvasively. Moreover, various aspects of the invention can be implemented using one or more channels and/or other components of a conventional pulse oximeter, thereby providing additional functionality to instruments that are widely available and trusted, as well as providing access to important information for treatment of patients on a cost-effective basis.
- In accordance with one aspect of the present invention, a pleth signal is analyzed to identify a heart rate variability parameter associated with respiration rate. The associated process involves obtaining a pleth signal, processing the pleth signal to obtain heart rate samples, monitoring the heart rate samples to identify a heart rate variability, and determining a respiration rate based on the heart rate variability. It is known that heart rate varies with the respiration cycle, an effect called Respiratory Sinus Arrhythmia. The present invention provides a robust process for monitoring this effect and determining respiration rate based on pleth signals. A novel processor and pulse oximeter incorporating such processing are also provided in accordance with the present invention.
- The step of obtaining a pleth signal generally involves receiving a digital signal representative of an optical signal modulated based on interaction with perfused tissue of a patient. Such a signal may be provided using components of a conventional pulse oximeter. Pulse oximeters typically transmit red and infrared signals, thereby yielding red and infrared pleths. Either or both of these pleths may be utilized in accordance with the present invention. In particular, each of these pleths generally has a fundamental frequency corresponding to the patient's heart rate. Accordingly, either pleth can be used to yield the desired heart rate information. In general, for normally oxygenated patients, the infrared channel typically has the stronger pleth waveform and may be preferred for heart rate calculations. For poorly oxygenated patients, the red pleth may be preferred. In many cases, a combination of the two signals may provide a better waveform for heart rate analysis than either signal alone.
- The pleth may be processed to obtain heart rate samples in a variety of ways. As noted above, the pleth is generally a periodic signal having a fundamental frequency corresponding to the patient's heart rate. Accordingly, heart rate may be determined by performing peak-to-peak measurements on the pleth to determine the pulse period and, hence, pulse frequency. For example, such maxima may be obtained by identifying a change in sign of differential values between successive samples or groups of samples along the pleth or of a function fitted to the pleth. Alternatively, other points on the waveform, such as nominal zero (or average pleth value) crossings may be monitored. Such zero crossings would be expected to have a frequency of twice the heart rate. Such period measurements can be complicated due to the typically noisy waveform of the pleths. Accordingly, multiple waveforms may be utilized.
- Additionally, the heart rate calculations may be performed in the frequency domain. In this regard, a processor may be configured to obtain a Fourier transform of the pleth. Once the Fourier transform is obtained, the pulse rate can be identified as the fundamental frequency of the pleth corresponding to the patient's heart rate. In any case, once the heart rate is determined, it can be monitored to identify low frequency variations associated with respiration. In particular, oscillatory variations having a frequency of between about 0.15 and 0.5 Hz and, especially, between about 0.2 and 0.4 Hz, are indicative of respiration rate. This range may be expanded to 0-5 Hz to accommodate the higher respiration rates of newborns.
- One or more filters may be used in determining respiration rate information based on a pleth signal in accordance with the present invention. In this regard, an adaptive filter may be used to track the fundamental frequency of the pleth and, hence, the patient's pulse rate. For example, such a filter may function as a narrow band pass filter having a band pass that is centered on the fundamental frequency of the pleth. The transfer function of the filter may be varied, e.g., based on analysis of successive waveforms, to track the changing fundamental frequency. The filter or associated logic may thus be adapted to output a time series of pulse rate values. Such a time series of pulse rate values, whether obtained as an output of an adaptive filter system or otherwise, may be filtered using a static band pass filter having a pass band including the noted frequencies of interest, or using an adaptive filter that tracks a selected spectral peak of the time series to provide an output indicative of respiration rate. Such filtering provides a fast, robust and computationally efficient mechanism for noninvasively monitoring patient respiration based on pleth signals.
- The present invention is based in part on a recognition that the pleth signal includes a variety of information in addition to the pulsatile waveform that is generally the focus of plethysmographic processing. In particular, it has been recognized that the pleth signal includes at least three additional or related components: 1) a component related to respiration or the “respiration wave”, 2) a low frequency component associated with the autonomic nervous system or vaso motor center, sometimes termed the “Mayer wave,” and 3) a very low frequency component which is associated with temperature control. Regarding the second of these, the origin and nature of the Mayer wave is not fully settled. For present purposes, the Mayer wave relates to a low frequency variation in blood pressure, heart rate, and/or vaso constriction.
- The first two components noted above have particular significance for diagnostic and patient monitoring purposes. In particular, the amplitude and frequency of the Mayer wave are seen to change in connection with hypertension, sudden cardiac death, ventricular tachycardia, coronary artery disease, myocardial infarction, heart failure, diabetes, and autonomic neuropathy and after heart transplantation. Respiration rate is monitored during a variety of medical procedures, for example, as an indication of a patient's stress levels and to identify patient respiratory distress. It is expected that both the Mayer and respiration waves influence heart rate (and related parameters such as variations in blood pressure and blood volume) by direct influence on the vaso motor center. In the latter case, this is by a “spillover” from the breathing center to the vaso motor center, which increases heart rate during inspiration.
- A difficulty associated with obtaining physiological parameter information based on the Mayer wave and the respiration wave relates to distinguishing the effects associated with these waves, particularly in view of the fact that each of these waves can occur within overlapping frequency ranges. In accordance with the present invention, respiration information is obtained by monitoring heart rate variability within a specific frequency band as noted above. In particular, by monitoring in a frequency range having a lower end of preferably at least about 0.15 Hz, for example, 0.15-0.5, interference due to Mayer wave effects can generally be minimized. Still better results may be obtained by monitoring a range between about 0.2-0.4 Hz or, especially, about 0.3 Hz. In the case of tracking respiration rate using an adaptive filter relative to a time series of pulse rate values or a corresponding frequency spectrum, the transfer function may be limited to track the respiration related peak only within these ranges using 0.3 Hz as an initial condition.
- For a more complete understanding of the present invention and further advantages thereof, reference is now made to the following detailed description, taken in conjunction with the drawings, in which:
- FIG. 1 is a schematic diagram of a pulse oximeter in accordance with the present invention;
- FIG. 2 illustrates the waveform of a pleth that may be used to obtain respiratory information in accordance with the present invention;
- FIG. 3 illustrates a pleth power spectrum showing the respiration related peak that is used in accordance with the present invention;
- FIG. 4 illustrates a heart rate time series generated using an appropriate filter in accordance with the present invention;
- FIG. 5 is a pleth power spectrum illustrating a transfer function of a filter in accordance with the present invention;
- FIG. 6 is a respiratory power spectrum illustrating a transfer function of another filter in accordance with the present invention;
- FIG. 7 is a flow chart illustrating a process for using a pleth signal to monitor respiration in accordance with the present invention; and
- FIG. 8 illustrates a signal processing system in accordance with the present invention.
- The present invention relates to obtaining physiological parameter information for a patient based on an analysis of a pleth involving distinguishing an effect associated with a Mayer wave component from an effect associated with a respiration wave component. In the following discussion, the invention is described in the context of an implementation utilizing components of a conventional pulse oximeter. The invention has particular advantages in this regard as such an implementation enhances the functionality of conventional pulse oximeters and provides important physiological parameter information in a cost effective manner. However, it will be appreciated that various aspects of the invention are not limited to such a pulse oximeter or other multi-channel signal implementation and the invention may be embodied in a dedicated single or multi-channel photoplethysmography instrument. Accordingly, the following discussion should be understood as exemplifying the invention and not by way of limitation.
- Referring to FIG. 1, a schematic diagram of a
pulse oximeter 100 in accordance with the present invention is shown. Theoximeter 100 generally includes aninstrument housing 102 and a probe 104 for attachment to afinger 101 or other appendage of a patient under analysis. In the illustrated embodiment, the probe 104 includes two ormore sources 106 and adetector 110. It will be appreciated that either or both of these components may alternatively be located in thehousing 102 and may be optically connected to the probe 104 by fiber optics or the like. Additionally, thesources 106 and/ordetector 110 may be located in the cable or other coupling operatively between the probe 104 and thehousing 102. Thesources 106 are driven by source drives 108. Thedrives 108 serve to modulate thesignals 103 in any of various ways. In this regard, thesignals 103 transmitted by thesources 106 may be time division multiplexed, frequency division multiplexed, code division multiplexed, or the like. Such multiplexing facilitates separation of the signals from each of the channels during hardware or software based signal processing. Thesources 106 provide two or more channels ofsignals 103. Each channel has a unique spectral content, e.g., wavelength or wavelength band. In the illustrated embodiment, twosources 106 are shown; one of the sources may have a red-centered wavelength and the other may have an infrared-centered wavelength. - The
signals 103 may be transmitted through or reflected by the patient's tissue. In either case, the signals are modulated by the patient's tissue to provide information regarding blood oxygen saturation in a manner that is well known. The transmitted signals 103 are received by thedetector 110 which, in the illustrated embodiment, provides an analogcurrent output signal 105 representative of the detected signals 103. Thisdetector signal 105 is then processed by signal processing module 112. The processing module 112 may include a number of components that may be embodied in software, firmware and/or hardware. These components may include components for amplifying thesignal 105 and converting the signal from a current signal to a voltage signal, filtering the signal to remove certain components of noise and otherwise conditioning the signal. In the illustrated embodiment, the signal processing module 112 also includes an analog to digital converter for converting the signal into a digital signal and a demultiplexer component for providing twoseparate output signals 118 or pleths that generally correspond to the two separate channel signals 103. Thesepleths 118 are then used byoxygenation calculation module 116 to compute a value related to blood oxygen saturation, e.g., a blood oxygen saturation percentage. A number of algorithms for performing such calculations are known and such calculation techniques are disclosed in U.S. Pat. Nos. 5,934,277 by Mortz and 5,842,979 by Jarman, both of which are incorporated herein by reference. - FIG. 2 illustrates an exemplary waveform of a pleth as such information may be obtained by the processor of a pulse oximeter. In particular, such information may be obtained as a digital signal output by the A/D converter, i.e., a time series of values related to the detector output. Such values are shown graphically in FIG. 2. As noted above, the pleth corresponding to either of the oximetry channels, or a combination of the channels, may be used in accordance with the present invention. It is desirable to obtain a strong pleth signal so that the waveform and pulse rate can be accurately identified. Accordingly, for normally oxygenated patients, the infrared channel pleth may be utilized. For poorly oxygenated patients, the red pleth may be preferred. In this regard, a cut off oxygenation level such as 85% may be used in determining whether to use the infrared or red pleth. Alternatively, the two pleth signals may be mathematically blended, depending on the current oxygenation level to obtain an optimized pleth for subsequent analysis in accordance with the present invention. Appropriate techniques for obtaining an optimized pleth signal are disclosed in U.S. patent application Ser. No. 09/975,289, which is disclosed herein by reference.
- As shown in FIG. 2, the pleth signal includes a pulsatile component having a period designated Tp. This period corresponds to the patient's heart rate. The heart rate can be determined by monitoring this pleth in a variety of ways such as identifying a change in sign of a differential value of the waveform (e.g., to perform a peak-to-peak period measurement or peak-to-trough ½ period measurement), tracking crossings of an average value indicated by A, or, as will be discussed in more detail below, by using a filter to track the fundamental frequency of the pleth.
- In accordance with the present invention, the patient's respiration is monitored by tracking low frequency heart rate changes. FIG. 3 shows an exemplary pleth power spectrum. The spectrum is characterized by three discrete peaks. These include a peak typically around 0.3 Hz-0.5 Hz, a peak typically around 0.1 Hz and a peak below 0.05 Hz. The peak below 0.05 Hz is generally linked with vaso motor control and temperature control. The peak at around 0.1 Hz is generally associated with the Mayer wave. As noted above, this phenomenon is not well understood but has been correlated to hypertension, sudden cardiac death, ventricular tachycardia, coronary artery disease, myocardial infarction, heart failure, diabetes, and autonomic neuropathy and has been seen to change after heart transplantation. The remaining peak, at about 0.3-0.5 Hz is believed to be correlated with respiration and is of particular interest for purposes of the present invention. It will be appreciated that this peak may be as high as 1 Hz or greater for newborns.
- FIG. 4 graphically illustrates the respiratory Sinus Arrhythmia phenomenon associated with the above noted respiration wave. In particular, FIG. 4 is a graph plotting the output of a heart rate filter, as will be discussed below, against time. As shown, the result is a periodic waveform having a period designated TB. This generally corresponds to a reduction in heart rate during the expiration portion of the respiratory cycle and an increase in heart rate during the inspiration portion of the cycle. The period of this waveform generally corresponds to the respiration rate and is tracked using a pulse oximeter in accordance with the present invention.
- From the foregoing discussion, it will be appreciated that respiration rate can be monitored by: 1) determining heart rate based on an analysis of the pleth signal, 2) monitoring this heart rate over time to obtain a time series heart rate values, and 3) analyzing the time series heart rate values to identify a respiration rate. These steps can be executed using adaptive filters and/or static band pass filters as discussed below.
- FIG. 5 illustrates a pleth power spectrum. Such a power spectrum may be obtained by configuring the oximeter processor to mathematically obtain a Fourier transform of the time domain pleth signal. As shown, the pleth power spectrum has a fundamental frequency at t0 corresponding to the patient's heart rate. Additional peaks of the illustrated power spectrum relate to harmonics thereof. The present invention utilizes an adaptive filter adapted to function as a band pass filter having a narrow band pass encompassing the fundamental frequency. The transfer function of this filter is generally indicated by
function 500. A variety of different types of filters may be used in this regard. Generally, such filters track the fundamental frequency of a signal based on certain programmed information regarding the nature of the signal as well as by monitoring successive signal waveforms. Such filters are robust in operation and can provide a continually updated output, in this case, regarding pulse rate. Thus, such a filter can provide as an output a time series of pulse rate values such as illustrated in FIG. 4. - An additional digital filter can be used to track respiration rate. In particular, the output of the heart rate filter can be processed to provide a respiratory power spectrum as shown in FIG. 6. For example, the oximeter processor can be configured to perform a Fourier transform on the time series of pulse rate values output by the heart rate filter. The resulting respiratory power spectrum includes a frequency peak correlated to the respiration rate designated as t0. The additional peaks shown in the power spectrum of FIG. 6 relate to harmonics thereof or other heart rate variations. An adaptive filter having a transfer function, generally indicated by
function 600, can be used to track the fundamental frequency. Such a filter may be similar to the heart rate filter as described above and is programmed to adaptively track the noted frequency of the respiratory power spectrum which corresponds to respiration rate. The output of this filter is a periodically updated respiration rate value. Alternatively, a static band pass filter may be used to isolate the peak related to respiration and, hence, identify the respiration rate. Such a filter may have a pass band of 0-0.5 Hz or, to accommodate neonatal applications, 0-1.5 Hz. - FIG. 7 is a flow chart illustrating a process for determining respiration rate based on pleth signals in accordance with the present invention. The
process 700 is initiated by obtaining a detector output or pleth signal. In the context of a pulse oximeter, this may involve receiving the digital output from an A/D converter that reflects the detector signal, demodulating this signal to obtain individual channel components and selecting a pleth for further processing. The selected pleth may be one of the channels or an optimized pleth based on both of the channel components. The pleth is then filtered (704) to obtain a time series of heart rate values. These values are monitored (706) over time to obtain a heart rate signal. The heart rate signal is then filtered (708) to identify a frequency peak correlated to respiration. The frequency of this peak is then output (710) as a respiration rate. This respiration rate may be displayed in the display area of a conventional pulse oximeter programmed to provide such information. - The corresponding components of a pulse oximeter processing unit are illustrated in FIG. 8. The
illustrative unit 800 includes an A/D converter 802. The A/D converter receives an analog signal representative of the optical signal received by the pulse oximeter detector. This analog input signal is processed by the converter (802) to provide adigital detector signal 803. Thedigital detector signal 803 is then processed bydemodulator 804 to provide two separate channel signals designated channel A (805) and channel B (807), that may correspond, for example, to the red and infrared channels of the pulse oximeter. These channel signals are then processed by the optimized pleth generator 806 to provide an optimizedpleth waveform 809. As discussed above, the optimized pleth waveform may correspond to either of the channel signals or a combination thereof. This optimizedwaveform 809 is processed by a heart rate filter in order to track the fundamental frequency of the waveform which corresponds to the patient's heart rate. The output from theheart rate filter 808 is a time series of heart rate values 811. This time series heart rate values is then processed by arespiration rate filter 810 which tracks a selected frequency of the corresponding spectrum to determinerespiration rate 813. The patient'srespiration rate 813 may be periodically output to a user via adisplay 812. - While various embodiments of the present invention have been described in detail, it is apparent that further modifications and adaptations of the invention will occur to those skilled in the art. However, it is to be expressly understood that such modifications and adaptations are within the spirit and scope of the present invention.
Claims (24)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/081,719 US6702752B2 (en) | 2002-02-22 | 2002-02-22 | Monitoring respiration based on plethysmographic heart rate signal |
AU2003217564A AU2003217564A1 (en) | 2002-02-22 | 2003-02-19 | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
PCT/US2003/004836 WO2003071938A1 (en) | 2002-02-22 | 2003-02-19 | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
EP20030713516 EP1485009A1 (en) | 2002-02-22 | 2003-02-19 | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
JP2003570689A JP2005535359A (en) | 2002-02-22 | 2003-02-19 | Monitoring physiological parameters based on fluctuations in photoplethysmographic signals |
CNA038083272A CN1646055A (en) | 2002-02-22 | 2003-02-19 | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
US10/790,950 US7001337B2 (en) | 2002-02-22 | 2004-03-02 | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/081,719 US6702752B2 (en) | 2002-02-22 | 2002-02-22 | Monitoring respiration based on plethysmographic heart rate signal |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/081,887 Continuation-In-Part US6805673B2 (en) | 2002-02-22 | 2002-02-22 | Monitoring mayer wave effects based on a photoplethysmographic signal |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/790,950 Continuation-In-Part US7001337B2 (en) | 2002-02-22 | 2004-03-02 | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
Publications (2)
Publication Number | Publication Date |
---|---|
US20030163054A1 true US20030163054A1 (en) | 2003-08-28 |
US6702752B2 US6702752B2 (en) | 2004-03-09 |
Family
ID=27752996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/081,719 Expired - Lifetime US6702752B2 (en) | 2002-02-22 | 2002-02-22 | Monitoring respiration based on plethysmographic heart rate signal |
Country Status (1)
Country | Link |
---|---|
US (1) | US6702752B2 (en) |
Cited By (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040225207A1 (en) * | 2003-05-09 | 2004-11-11 | Sang-Kon Bae | Ear type apparatus for measuring a bio signal and measuring method therefor |
US20050209521A1 (en) * | 2002-05-29 | 2005-09-22 | Joni Kettunen | Procedure for deriving reliable information on respiratory activity from heart period measurement |
US20060004405A1 (en) * | 2001-10-18 | 2006-01-05 | Amr Salahieh | Vascular embolic filter devices and methods of use therefor |
US20060009971A1 (en) * | 2004-06-30 | 2006-01-12 | Kushner William M | Method and apparatus for characterizing inhalation noise and calculating parameters based on the characterization |
US20060009970A1 (en) * | 2004-06-30 | 2006-01-12 | Harton Sara M | Method for detecting and attenuating inhalation noise in a communication system |
US20060020451A1 (en) * | 2004-06-30 | 2006-01-26 | Kushner William M | Method and apparatus for equalizing a speech signal generated within a pressurized air delivery system |
US20070021673A1 (en) * | 2004-01-27 | 2007-01-25 | Cardiometer Ltd. | Method and system for cardiovascular system diagnosis |
EP1757225A1 (en) * | 2005-08-26 | 2007-02-28 | Nihon Kohden Corporation | Apparataus and method for measuring pulse rate |
US20070056582A1 (en) * | 2005-03-18 | 2007-03-15 | Michael Wood | Methods and devices for relieving stress |
GB2438070A (en) * | 2006-05-12 | 2007-11-14 | Suunto Oy | Determining energy consumption during exercise from respiratory frequency derived from heart rate measurements |
US20080249422A1 (en) * | 2007-04-05 | 2008-10-09 | Stephen Bennett Elliott | Method and system for improving physiologic status and health via assessment of the dynamic respiratory arterial pressure wave using plethysmographic technique |
US20100004552A1 (en) * | 2006-12-21 | 2010-01-07 | Fresenius Medical Care Deutschland Gmbh | Method and device for the determination of breath frequency |
US7691049B2 (en) | 2004-03-18 | 2010-04-06 | Respironics, Inc. | Methods and devices for relieving stress |
US20100106030A1 (en) * | 2008-10-23 | 2010-04-29 | Mason Gregory R | Method and system for automated measurement of pulsus paradoxus |
US20100113904A1 (en) * | 2008-11-05 | 2010-05-06 | Nellcor Puritan Bennett Llc | System And Method For Facilitating Observation Of Monitored Physiologic Data |
WO2010082200A1 (en) * | 2009-01-14 | 2010-07-22 | Widemed Ltd. | Method and system for detecting a respiratory signal |
US20100222655A1 (en) * | 2003-12-01 | 2010-09-02 | Ric Investments, Llc | Apparatus and method for monitoring pressure related changes in the extra-thoracic arterial circulatory system |
US20100298730A1 (en) * | 2007-07-30 | 2010-11-25 | Oxford Biosignals Limited | Method and apparatus for measuring breathing rate |
US20120172688A1 (en) * | 2007-12-06 | 2012-07-05 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Method and system for detection of respiratory variation in plethysmographic oximetry |
US8398555B2 (en) | 2008-09-10 | 2013-03-19 | Covidien Lp | System and method for detecting ventilatory instability |
US8641631B2 (en) | 2004-04-08 | 2014-02-04 | Masimo Corporation | Non-invasive monitoring of respiratory rate, heart rate and apnea |
US20140039283A1 (en) * | 2012-07-31 | 2014-02-06 | Periodic Breathing Foundation | System for analyzing oximetry data |
US8755871B2 (en) | 2011-11-30 | 2014-06-17 | Covidien Lp | Systems and methods for detecting arrhythmia from a physiological signal |
US8880576B2 (en) | 2011-09-23 | 2014-11-04 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US8880155B2 (en) | 2012-02-24 | 2014-11-04 | Covidien Lp | Hypovolemia diagnosis technique |
US9066680B1 (en) | 2009-10-15 | 2015-06-30 | Masimo Corporation | System for determining confidence in respiratory rate measurements |
US9119597B2 (en) | 2011-09-23 | 2015-09-01 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9179876B2 (en) | 2012-04-30 | 2015-11-10 | Nellcor Puritan Bennett Ireland | Systems and methods for identifying portions of a physiological signal usable for determining physiological information |
US9247896B2 (en) | 2012-01-04 | 2016-02-02 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information using phase locked loop |
US9307928B1 (en) * | 2010-03-30 | 2016-04-12 | Masimo Corporation | Plethysmographic respiration processor |
US20160143566A1 (en) * | 2014-11-20 | 2016-05-26 | Qualcomm Incorporated | Circuitry to Allow Low Current Operation of a Device Capable of Determining a Blood Property |
US9402554B2 (en) | 2011-09-23 | 2016-08-02 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
EP3066978A1 (en) * | 2003-12-30 | 2016-09-14 | Beta Biomed Services, Inc. | Method and system of monitoring respiration in an individual |
US9554712B2 (en) | 2013-02-27 | 2017-01-31 | Covidien Lp | Systems and methods for generating an artificial photoplethysmograph signal |
US9560978B2 (en) | 2013-02-05 | 2017-02-07 | Covidien Lp | Systems and methods for determining respiration information from a physiological signal using amplitude demodulation |
US20170055846A1 (en) * | 2015-08-28 | 2017-03-02 | Oslermd, Inc. | Methods and apparatuses for measuring multiple vital signs based on arterial pressure waveforms |
CN106725491A (en) * | 2017-02-16 | 2017-05-31 | 王丽燕 | A kind of respiratory rate method for determining child patient |
US9668695B2 (en) | 2004-08-11 | 2017-06-06 | University Of Florida Research Foundation, Inc. | Pulse oximeter probes and methods for using the same |
US9675274B2 (en) | 2011-09-23 | 2017-06-13 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9687159B2 (en) | 2013-02-27 | 2017-06-27 | Covidien Lp | Systems and methods for determining physiological information by identifying fiducial points in a physiological signal |
US9693709B2 (en) | 2011-09-23 | 2017-07-04 | Nellcot Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9693736B2 (en) | 2011-11-30 | 2017-07-04 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information using historical distribution |
US9724016B1 (en) | 2009-10-16 | 2017-08-08 | Masimo Corp. | Respiration processor |
US9801579B2 (en) | 2012-03-19 | 2017-10-31 | Fujitsu Limited | Arousal-level determining apparatus and arousal-level determining method |
US9848820B2 (en) | 2014-01-07 | 2017-12-26 | Covidien Lp | Apnea analysis system and method |
US9901308B2 (en) | 2014-02-20 | 2018-02-27 | Covidien Lp | Systems and methods for filtering autocorrelation peaks and detecting harmonics |
US10022068B2 (en) | 2013-10-28 | 2018-07-17 | Covidien Lp | Systems and methods for detecting held breath events |
US20180333102A1 (en) * | 2015-12-01 | 2018-11-22 | Koninklijke Philips N.V. | Device, system and method for determining vital sign information of a subject |
US10159842B2 (en) | 2015-08-28 | 2018-12-25 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US20190261890A1 (en) * | 2015-06-01 | 2019-08-29 | Pixart Imaging Inc. | Optical respiration rate detection device |
US10441181B1 (en) | 2013-03-13 | 2019-10-15 | Masimo Corporation | Acoustic pulse and respiration monitoring system |
US11006843B1 (en) | 2020-08-20 | 2021-05-18 | Cloud Dx, Inc. | System and method of determining breathing rates from oscillometric data |
US11229374B2 (en) | 2006-12-09 | 2022-01-25 | Masimo Corporation | Plethysmograph variability processor |
US11259749B2 (en) | 2004-08-11 | 2022-03-01 | Koninklijke Philips N.V. | Pulse oximeter probes and methods for using the same |
US11272859B1 (en) | 2020-08-20 | 2022-03-15 | Cloud Dx, Inc. | System and method of determining respiratory status from oscillometric data |
Families Citing this family (143)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6018673A (en) | 1996-10-10 | 2000-01-25 | Nellcor Puritan Bennett Incorporated | Motion compatible sensor for non-invasive optical blood analysis |
US6675031B1 (en) | 1999-04-14 | 2004-01-06 | Mallinckrodt Inc. | Method and circuit for indicating quality and accuracy of physiological measurements |
AU5359901A (en) | 2000-04-17 | 2001-10-30 | Vivometrics Inc | Systems and methods for ambulatory monitoring of physiological signs |
US7666151B2 (en) * | 2002-11-20 | 2010-02-23 | Hoana Medical, Inc. | Devices and methods for passive patient monitoring |
US6748254B2 (en) | 2001-10-12 | 2004-06-08 | Nellcor Puritan Bennett Incorporated | Stacked adhesive optical sensor |
WO2003071938A1 (en) * | 2002-02-22 | 2003-09-04 | Datex-Ohmeda, Inc. | Monitoring physiological parameters based on variations in a photoplethysmographic signal |
KR100455289B1 (en) * | 2002-03-16 | 2004-11-08 | 삼성전자주식회사 | Method of diagnosing using a ray and apparatus thereof |
US6783498B2 (en) * | 2002-03-26 | 2004-08-31 | Vivometrics, Inc. | Method and system for extracting cardiac parameters from plethysmographic signals |
US8790272B2 (en) * | 2002-03-26 | 2014-07-29 | Adidas Ag | Method and system for extracting cardiac parameters from plethysmographic signals |
US7407486B2 (en) * | 2002-10-14 | 2008-08-05 | Ge Healthcare Finland Oy | Method and an apparatus for pulse plethysmograph based detection of nociception during anesthesia or sedation |
US7190986B1 (en) | 2002-10-18 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Non-adhesive oximeter sensor for sensitive skin |
US8255029B2 (en) | 2003-02-27 | 2012-08-28 | Nellcor Puritan Bennett Llc | Method of analyzing and processing signals |
WO2004080300A1 (en) * | 2003-03-12 | 2004-09-23 | Yale University | Method of assesing blood volume using photoelectric plethysmography |
US20080082018A1 (en) * | 2003-04-10 | 2008-04-03 | Sackner Marvin A | Systems and methods for respiratory event detection |
US7689271B1 (en) | 2003-06-26 | 2010-03-30 | Hoana Medical, Inc. | Non-invasive heart rate and respiration measurements from extremities |
JP5466351B2 (en) | 2003-11-18 | 2014-04-09 | アディダス アーゲー | Method and system for processing data from mobile physiological monitoring |
US7771364B2 (en) * | 2004-01-27 | 2010-08-10 | Spirocor Ltd. | Method and system for cardiovascular system diagnosis |
US7435214B2 (en) * | 2004-01-29 | 2008-10-14 | Cannuflow, Inc. | Atraumatic arthroscopic instrument sheath |
US9492084B2 (en) | 2004-06-18 | 2016-11-15 | Adidas Ag | Systems and methods for monitoring subjects in potential physiological distress |
US9504410B2 (en) * | 2005-09-21 | 2016-11-29 | Adidas Ag | Band-like garment for physiological monitoring |
US20060253010A1 (en) * | 2004-09-28 | 2006-11-09 | Donald Brady | Monitoring device, method and system |
US7887492B1 (en) | 2004-09-28 | 2011-02-15 | Impact Sports Technologies, Inc. | Monitoring device, method and system |
US20060079794A1 (en) * | 2004-09-28 | 2006-04-13 | Impact Sports Technologies, Inc. | Monitoring device, method and system |
AU2011203234B2 (en) * | 2004-10-06 | 2013-01-10 | Resmed Limited | Method and Apparatus for Non-Invasive Monitoring of Respiratory Parameters in Sleep Disordered Breathing |
NZ589369A (en) * | 2004-10-06 | 2012-03-30 | Resmed Ltd | Using oximeter and airflow signals to process two signals and with further processor to generate results based on the two signals |
US7578793B2 (en) * | 2004-11-22 | 2009-08-25 | Widemed Ltd. | Sleep staging based on cardio-respiratory signals |
EP1848336A4 (en) * | 2005-02-07 | 2009-11-11 | Widemed Ltd | Detection and monitoring of stress events during sleep |
US7635337B2 (en) * | 2005-03-24 | 2009-12-22 | Ge Healthcare Finland Oy | Determination of clinical stress of a subject in pulse oximetry |
WO2006113804A2 (en) * | 2005-04-20 | 2006-10-26 | Vivometrics, Inc. | Systems and methods for non-invasive physiological monitoring of non-human animals |
CA2606699C (en) | 2005-05-20 | 2017-04-18 | Vivometrics, Inc. | Methods and systems for determining dynamic hyperinflation |
US8033996B2 (en) | 2005-07-26 | 2011-10-11 | Adidas Ag | Computer interfaces including physiologically guided avatars |
US7657295B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7657294B2 (en) | 2005-08-08 | 2010-02-02 | Nellcor Puritan Bennett Llc | Compliant diaphragm medical sensor and technique for using the same |
US7590439B2 (en) | 2005-08-08 | 2009-09-15 | Nellcor Puritan Bennett Llc | Bi-stable medical sensor and technique for using the same |
US20070060808A1 (en) | 2005-09-12 | 2007-03-15 | Carine Hoarau | Medical sensor for reducing motion artifacts and technique for using the same |
US7904130B2 (en) | 2005-09-29 | 2011-03-08 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8092379B2 (en) | 2005-09-29 | 2012-01-10 | Nellcor Puritan Bennett Llc | Method and system for determining when to reposition a physiological sensor |
US7869850B2 (en) | 2005-09-29 | 2011-01-11 | Nellcor Puritan Bennett Llc | Medical sensor for reducing motion artifacts and technique for using the same |
US7899510B2 (en) | 2005-09-29 | 2011-03-01 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US7486979B2 (en) | 2005-09-30 | 2009-02-03 | Nellcor Puritan Bennett Llc | Optically aligned pulse oximetry sensor and technique for using the same |
US20070077200A1 (en) * | 2005-09-30 | 2007-04-05 | Baker Clark R | Method and system for controlled maintenance of hypoxia for therapeutic or diagnostic purposes |
US7555327B2 (en) | 2005-09-30 | 2009-06-30 | Nellcor Puritan Bennett Llc | Folding medical sensor and technique for using the same |
US8062221B2 (en) | 2005-09-30 | 2011-11-22 | Nellcor Puritan Bennett Llc | Sensor for tissue gas detection and technique for using the same |
US8233954B2 (en) | 2005-09-30 | 2012-07-31 | Nellcor Puritan Bennett Llc | Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same |
US7881762B2 (en) | 2005-09-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US7483731B2 (en) | 2005-09-30 | 2009-01-27 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8762733B2 (en) * | 2006-01-30 | 2014-06-24 | Adidas Ag | System and method for identity confirmation using physiologic biometrics to determine a physiologic fingerprint |
US20070270671A1 (en) * | 2006-04-10 | 2007-11-22 | Vivometrics, Inc. | Physiological signal processing devices and associated processing methods |
US8073518B2 (en) | 2006-05-02 | 2011-12-06 | Nellcor Puritan Bennett Llc | Clip-style medical sensor and technique for using the same |
US8475387B2 (en) * | 2006-06-20 | 2013-07-02 | Adidas Ag | Automatic and ambulatory monitoring of congestive heart failure patients |
US8145288B2 (en) | 2006-08-22 | 2012-03-27 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8219170B2 (en) | 2006-09-20 | 2012-07-10 | Nellcor Puritan Bennett Llc | System and method for practicing spectrophotometry using light emitting nanostructure devices |
US8359079B2 (en) * | 2006-09-21 | 2013-01-22 | Starr Life Sciences Corporation | Pulse oximetry system and techniques for deriving cardiac and breathing parameters from extra-thoracic blood flow measurements |
US20080076991A1 (en) * | 2006-09-21 | 2008-03-27 | Starr Life Sciences Corp. | Medical display devices for cardiac and breathing parameters derived from extra-thoracic blood flow measurements |
US7922666B2 (en) * | 2006-09-21 | 2011-04-12 | Starr Life Sciences Corporation | Pulse oximeter based techniques for controlling anesthesia levels and ventilation levels in subjects |
US8195264B2 (en) | 2006-09-22 | 2012-06-05 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US8396527B2 (en) | 2006-09-22 | 2013-03-12 | Covidien Lp | Medical sensor for reducing signal artifacts and technique for using the same |
US8175671B2 (en) | 2006-09-22 | 2012-05-08 | Nellcor Puritan Bennett Llc | Medical sensor for reducing signal artifacts and technique for using the same |
US7869849B2 (en) | 2006-09-26 | 2011-01-11 | Nellcor Puritan Bennett Llc | Opaque, electrically nonconductive region on a medical sensor |
US7574245B2 (en) | 2006-09-27 | 2009-08-11 | Nellcor Puritan Bennett Llc | Flexible medical sensor enclosure |
US8123695B2 (en) * | 2006-09-27 | 2012-02-28 | Nellcor Puritan Bennett Llc | Method and apparatus for detection of venous pulsation |
US7796403B2 (en) | 2006-09-28 | 2010-09-14 | Nellcor Puritan Bennett Llc | Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit |
US7890153B2 (en) | 2006-09-28 | 2011-02-15 | Nellcor Puritan Bennett Llc | System and method for mitigating interference in pulse oximetry |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US7680522B2 (en) | 2006-09-29 | 2010-03-16 | Nellcor Puritan Bennett Llc | Method and apparatus for detecting misapplied sensors |
US7476131B2 (en) | 2006-09-29 | 2009-01-13 | Nellcor Puritan Bennett Llc | Device for reducing crosstalk |
US7684842B2 (en) | 2006-09-29 | 2010-03-23 | Nellcor Puritan Bennett Llc | System and method for preventing sensor misuse |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US9833184B2 (en) * | 2006-10-27 | 2017-12-05 | Adidas Ag | Identification of emotional states using physiological responses |
US8646447B2 (en) * | 2006-11-13 | 2014-02-11 | Resmed Limited | Systems, methods, and/or apparatuses for non-invasive monitoring of respiratory parameters in sleep disordered breathing |
KR100882440B1 (en) * | 2006-11-27 | 2009-02-06 | 삼성전자주식회사 | Biosignal-detecting apparatus and mrthod of operating the apparatus |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US8652040B2 (en) | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
US8229530B2 (en) * | 2007-03-09 | 2012-07-24 | Nellcor Puritan Bennett Llc | System and method for detection of venous pulsation |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US7894869B2 (en) | 2007-03-09 | 2011-02-22 | Nellcor Puritan Bennett Llc | Multiple configuration medical sensor and technique for using the same |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US8221326B2 (en) * | 2007-03-09 | 2012-07-17 | Nellcor Puritan Bennett Llc | Detection of oximetry sensor sites based on waveform characteristics |
US8109882B2 (en) * | 2007-03-09 | 2012-02-07 | Nellcor Puritan Bennett Llc | System and method for venous pulsation detection using near infrared wavelengths |
US20080262326A1 (en) * | 2007-04-19 | 2008-10-23 | Starr Life Sciences Corp. | Signal Processing Method and Apparatus for Processing a Physiologic Signal such as a Photoplethysmography Signal |
US20080300500A1 (en) * | 2007-05-30 | 2008-12-04 | Widemed Ltd. | Apnea detection using a capnograph |
US8251903B2 (en) | 2007-10-25 | 2012-08-28 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
US8352004B2 (en) | 2007-12-21 | 2013-01-08 | Covidien Lp | Medical sensor and technique for using the same |
US8346328B2 (en) | 2007-12-21 | 2013-01-01 | Covidien Lp | Medical sensor and technique for using the same |
US8366613B2 (en) | 2007-12-26 | 2013-02-05 | Covidien Lp | LED drive circuit for pulse oximetry and method for using same |
US8577434B2 (en) | 2007-12-27 | 2013-11-05 | Covidien Lp | Coaxial LED light sources |
US8452364B2 (en) | 2007-12-28 | 2013-05-28 | Covidien LLP | System and method for attaching a sensor to a patient's skin |
US8442608B2 (en) | 2007-12-28 | 2013-05-14 | Covidien Lp | System and method for estimating physiological parameters by deconvolving artifacts |
US8199007B2 (en) | 2007-12-31 | 2012-06-12 | Nellcor Puritan Bennett Llc | Flex circuit snap track for a biometric sensor |
US8897850B2 (en) | 2007-12-31 | 2014-11-25 | Covidien Lp | Sensor with integrated living hinge and spring |
US8070508B2 (en) | 2007-12-31 | 2011-12-06 | Nellcor Puritan Bennett Llc | Method and apparatus for aligning and securing a cable strain relief |
US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
US8112375B2 (en) | 2008-03-31 | 2012-02-07 | Nellcor Puritan Bennett Llc | Wavelength selection and outlier detection in reduced rank linear models |
US7887345B2 (en) | 2008-06-30 | 2011-02-15 | Nellcor Puritan Bennett Llc | Single use connector for pulse oximetry sensors |
US20090326402A1 (en) * | 2008-06-30 | 2009-12-31 | Nellcor Puritan Bennett Ireland | Systems and methods for determining effort |
US8071935B2 (en) | 2008-06-30 | 2011-12-06 | Nellcor Puritan Bennett Llc | Optical detector with an overmolded faraday shield |
US7880884B2 (en) | 2008-06-30 | 2011-02-01 | Nellcor Puritan Bennett Llc | System and method for coating and shielding electronic sensor components |
US20100030040A1 (en) | 2008-08-04 | 2010-02-04 | Masimo Laboratories, Inc. | Multi-stream data collection system for noninvasive measurement of blood constituents |
US8577431B2 (en) | 2008-07-03 | 2013-11-05 | Cercacor Laboratories, Inc. | Noise shielding for a noninvasive device |
US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
US8914088B2 (en) | 2008-09-30 | 2014-12-16 | Covidien Lp | Medical sensor and technique for using the same |
US8423112B2 (en) | 2008-09-30 | 2013-04-16 | Covidien Lp | Medical sensor and technique for using the same |
US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
US9155493B2 (en) | 2008-10-03 | 2015-10-13 | Nellcor Puritan Bennett Ireland | Methods and apparatus for calibrating respiratory effort from photoplethysmograph signals |
US9011347B2 (en) | 2008-10-03 | 2015-04-21 | Nellcor Puritan Bennett Ireland | Methods and apparatus for determining breathing effort characteristics measures |
ES2336997B1 (en) * | 2008-10-16 | 2011-06-13 | Sabirmedical,S.L. | SYSTEM AND APPARATUS FOR NON-INVASIVE MEASUREMENT OF BLOOD PRESSURE. |
US8788002B2 (en) | 2009-02-25 | 2014-07-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
EP3127476A1 (en) | 2009-02-25 | 2017-02-08 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US8452366B2 (en) | 2009-03-16 | 2013-05-28 | Covidien Lp | Medical monitoring device with flexible circuitry |
US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
US8634891B2 (en) | 2009-05-20 | 2014-01-21 | Covidien Lp | Method and system for self regulation of sensor component contact pressure |
US8444570B2 (en) * | 2009-06-09 | 2013-05-21 | Nellcor Puritan Bennett Ireland | Signal processing techniques for aiding the interpretation of respiration signals |
US20100331716A1 (en) * | 2009-06-26 | 2010-12-30 | Nellcor Puritan Bennett Ireland | Methods and apparatus for measuring respiratory function using an effort signal |
US20100331715A1 (en) * | 2009-06-30 | 2010-12-30 | Nellcor Puritan Bennett Ireland | Systems and methods for detecting effort events |
US8311601B2 (en) | 2009-06-30 | 2012-11-13 | Nellcor Puritan Bennett Llc | Reflectance and/or transmissive pulse oximeter |
US8505821B2 (en) | 2009-06-30 | 2013-08-13 | Covidien Lp | System and method for providing sensor quality assurance |
US9010634B2 (en) | 2009-06-30 | 2015-04-21 | Covidien Lp | System and method for linking patient data to a patient and providing sensor quality assurance |
US8391941B2 (en) | 2009-07-17 | 2013-03-05 | Covidien Lp | System and method for memory switching for multiple configuration medical sensor |
US8755854B2 (en) | 2009-07-31 | 2014-06-17 | Nellcor Puritan Bennett Ireland | Methods and apparatus for producing and using lightly filtered photoplethysmograph signals |
US8417310B2 (en) | 2009-08-10 | 2013-04-09 | Covidien Lp | Digital switching in multi-site sensor |
US8428675B2 (en) | 2009-08-19 | 2013-04-23 | Covidien Lp | Nanofiber adhesives used in medical devices |
US8596270B2 (en) * | 2009-08-20 | 2013-12-03 | Covidien Lp | Systems and methods for controlling a ventilator |
US8400149B2 (en) * | 2009-09-25 | 2013-03-19 | Nellcor Puritan Bennett Ireland | Systems and methods for gating an imaging device |
US8498683B2 (en) | 2010-04-30 | 2013-07-30 | Covidien LLP | Method for respiration rate and blood pressure alarm management |
US8834378B2 (en) | 2010-07-30 | 2014-09-16 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiratory effort |
US8888701B2 (en) | 2011-01-27 | 2014-11-18 | Valencell, Inc. | Apparatus and methods for monitoring physiological data during environmental interference |
US9109902B1 (en) | 2011-06-13 | 2015-08-18 | Impact Sports Technologies, Inc. | Monitoring device with a pedometer |
EP2739207B1 (en) | 2011-08-02 | 2017-07-19 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
CN104168828A (en) | 2012-01-16 | 2014-11-26 | 瓦伦赛尔公司 | Physiological metric estimation rise and fall limiting |
JP6116017B2 (en) | 2012-01-16 | 2017-04-19 | ヴァレンセル,インコーポレイテッドValencell, Inc. | Reduction of physiological measurement error by inertia rhythm |
KR102025571B1 (en) * | 2012-07-27 | 2019-09-27 | 삼성전자주식회사 | Apparatus and method for measuring change in blood pressure caused by breathing control |
US9078575B2 (en) | 2013-10-30 | 2015-07-14 | Apn Health, Llc | Heartbeat categorization |
US9179849B1 (en) | 2014-07-25 | 2015-11-10 | Impact Sports Technologies, Inc. | Mobile plethysmographic device |
US10328202B2 (en) * | 2015-02-04 | 2019-06-25 | Covidien Lp | Methods and systems for determining fluid administration |
US10499835B2 (en) | 2015-03-24 | 2019-12-10 | Covidien Lp | Methods and systems for determining fluid responsiveness in the presence of noise |
US9801587B2 (en) | 2015-10-19 | 2017-10-31 | Garmin Switzerland Gmbh | Heart rate monitor with time varying linear filtering |
US10610158B2 (en) | 2015-10-23 | 2020-04-07 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
US10966662B2 (en) | 2016-07-08 | 2021-04-06 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
JP7146733B2 (en) * | 2016-07-18 | 2022-10-04 | ビオプティックス・インコーポレイテッド | Oxygen measurement device with laparoscopic dilation |
EP3624690B1 (en) | 2017-05-15 | 2023-12-20 | Agency for Science, Technology and Research | Method and system for respiratory measurement |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3704706A (en) | 1969-10-23 | 1972-12-05 | Univ Drexel | Heart rate and respiratory monitor |
US4306567A (en) | 1977-12-22 | 1981-12-22 | Krasner Jerome L | Detection and monitoring device |
US4379460A (en) | 1980-09-18 | 1983-04-12 | Judell Neil H K | Method and apparatus for removing cardiac artifact in impedance plethysmographic respiration monitoring |
US4404974A (en) | 1981-08-07 | 1983-09-20 | Possis Medical, Inc. | Method and apparatus for monitoring and displaying heart rate and blood pressure product information |
US4510944A (en) | 1982-12-30 | 1985-04-16 | Porges Stephen W | Method and apparatus for evaluating rhythmic oscillations in aperiodic physiological response systems |
US4781201A (en) | 1984-12-27 | 1988-11-01 | American Home Products Corporation (Del.) | Cardiovascular artifact filter |
JPS61228831A (en) | 1985-04-02 | 1986-10-13 | ミノルタ株式会社 | Apparatus for detecting non-respiration fit |
DE3536491A1 (en) | 1985-10-12 | 1987-04-16 | Morgenstern Juergen | DEVICE FOR MONITORING BREATHABILITY AND HEART ACTIVITY |
DE3604986A1 (en) | 1986-02-17 | 1987-08-20 | Hellige Gmbh | DEVICE FOR PREVENTING OXYGEN LACK DAMAGE |
US4777960A (en) | 1986-08-18 | 1988-10-18 | Massachusetts Institute Of Technology | Method and apparatus for the assessment of autonomic response by broad-band excitation |
US4899760A (en) | 1987-06-15 | 1990-02-13 | Colin Electronics Co., Ltd. | Noise rejecting detector for biomedical signals |
US4860759A (en) | 1987-09-08 | 1989-08-29 | Criticare Systems, Inc. | Vital signs monitor |
US4863265A (en) | 1987-10-16 | 1989-09-05 | Mine Safety Appliances Company | Apparatus and method for measuring blood constituents |
US4858638A (en) | 1987-11-10 | 1989-08-22 | Sloan Valve Company | Fast-acting quick release valve |
US5078136A (en) | 1988-03-30 | 1992-01-07 | Nellcor Incorporated | Method and apparatus for calculating arterial oxygen saturation based plethysmographs including transients |
US4869254A (en) | 1988-03-30 | 1989-09-26 | Nellcor Incorporated | Method and apparatus for calculating arterial oxygen saturation |
JPH06169902A (en) | 1988-05-05 | 1994-06-21 | Sentinel Monitoring Inc | Pulse type non-invasion type oxymeter and technology for measuring it |
US4972842A (en) | 1988-06-09 | 1990-11-27 | Vital Signals, Inc. | Method and apparatus for precision monitoring of infants on assisted ventilation |
US4958638A (en) | 1988-06-30 | 1990-09-25 | Georgia Tech Research Corporation | Non-contact vital signs monitor |
US4960129A (en) | 1988-12-05 | 1990-10-02 | Trustees Of The University Of Pennsylvania | Methods of observing autonomic neural stimulation and diagnosing cardiac dynamical dysfunction using heartbeat interval data to analyze cardioventilatory interactions |
US5111817A (en) | 1988-12-29 | 1992-05-12 | Medical Physics, Inc. | Noninvasive system and method for enhanced arterial oxygen saturation determination and arterial blood pressure monitoring |
US5423322A (en) | 1988-12-29 | 1995-06-13 | Medical Physics, Inc. | Total compliance method and apparatus for noninvasive arterial blood pressure measurement |
US5511553A (en) | 1989-02-15 | 1996-04-30 | Segalowitz; Jacob | Device-system and method for monitoring multiple physiological parameters (MMPP) continuously and simultaneously |
US5033472A (en) | 1989-02-23 | 1991-07-23 | Nihon Kohden Corp. | Method of and apparatus for analyzing propagation of arterial pulse waves through the circulatory system |
US5902235A (en) | 1989-03-29 | 1999-05-11 | Somanetics Corporation | Optical cerebral oximeter |
US4930517A (en) | 1989-04-25 | 1990-06-05 | Massachusetts Institute Of Technology | Method and apparatus for physiologic system identification |
DE68916803T2 (en) | 1989-12-23 | 1994-10-27 | Hewlett Packard Gmbh | Method for obtaining a respiratory signal and / or a cardiac disturbance signal from a physiological signal. |
SE465551B (en) | 1990-02-16 | 1991-09-30 | Aake Oeberg | DEVICE FOR DETERMINING A HEART AND RESPIRATORY FREQUENCY THROUGH PHOTOPLETISMOGRAPHICAL SEATING |
US5490505A (en) | 1991-03-07 | 1996-02-13 | Masimo Corporation | Signal processing apparatus |
EP1357481A3 (en) | 1991-03-07 | 2005-04-27 | Masimo Corporation | Signal processing apparatus and method |
US5273036A (en) | 1991-04-03 | 1993-12-28 | Ppg Industries, Inc. | Apparatus and method for monitoring respiration |
US5934277A (en) | 1991-09-03 | 1999-08-10 | Datex-Ohmeda, Inc. | System for pulse oximetry SpO2 determination |
ATE172623T1 (en) | 1991-12-17 | 1998-11-15 | Dynamics Imaging Inc | METHOD AND DEVICE FOR DIAGNOSING LIVING ORGANISMS |
US5818048A (en) | 1992-07-15 | 1998-10-06 | Optix Lp | Rapid non-invasive optical analysis using broad bandpass spectral processing |
JPH0638965A (en) | 1992-07-23 | 1994-02-15 | Minolta Camera Co Ltd | Respiration diagnostic apparatus |
US5368224A (en) | 1992-10-23 | 1994-11-29 | Nellcor Incorporated | Method for reducing ambient noise effects in electronic monitoring instruments |
JP2979933B2 (en) | 1993-08-03 | 1999-11-22 | セイコーエプソン株式会社 | Pulse wave analyzer |
US5553615A (en) | 1994-01-31 | 1996-09-10 | Minnesota Mining And Manufacturing Company | Method and apparatus for noninvasive prediction of hematocrit |
US5575284A (en) | 1994-04-01 | 1996-11-19 | University Of South Florida | Portable pulse oximeter |
US5853364A (en) | 1995-08-07 | 1998-12-29 | Nellcor Puritan Bennett, Inc. | Method and apparatus for estimating physiological parameters using model-based adaptive filtering |
US5980463A (en) | 1995-09-28 | 1999-11-09 | Data Sciences International, Inc. | Method for respiratory tidal volume measurement |
IL116020A (en) | 1995-11-16 | 2000-06-01 | Optelmed Ltd | Apparatus and method for measuring the variability of cardiovascular parameters |
US5766127A (en) | 1996-04-15 | 1998-06-16 | Ohmeda Inc. | Method and apparatus for improved photoplethysmographic perfusion-index monitoring |
JP3666987B2 (en) | 1996-05-02 | 2005-06-29 | コーリンメディカルテクノロジー株式会社 | Blood pressure monitoring device |
US5931779A (en) | 1996-06-06 | 1999-08-03 | Wisconsin Alumni Research Foundation | Real-time in-vivo measurement of myoglobin oxygen saturation |
CN1203805C (en) * | 1996-09-10 | 2005-06-01 | 精工爱普生株式会社 | Organism state measuring device and relaxation instructing device |
US5830137A (en) | 1996-11-18 | 1998-11-03 | University Of South Florida | Green light pulse oximeter |
SE9604320D0 (en) | 1996-11-25 | 1996-11-25 | Pacesetter Ab | Medical device |
US5842979A (en) | 1997-02-14 | 1998-12-01 | Ohmeda Inc. | Method and apparatus for improved photoplethysmographic monitoring of oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin |
JP2956833B2 (en) | 1997-02-19 | 1999-10-04 | 日本電気株式会社 | Evaluation method of polycrystalline silicon film |
US5954644A (en) | 1997-03-24 | 1999-09-21 | Ohmeda Inc. | Method for ambient light subtraction in a photoplethysmographic measurement instrument |
US6002952A (en) | 1997-04-14 | 1999-12-14 | Masimo Corporation | Signal processing apparatus and method |
US5919134A (en) | 1997-04-14 | 1999-07-06 | Masimo Corp. | Method and apparatus for demodulating signals in a pulse oximetry system |
US5865756A (en) | 1997-06-06 | 1999-02-02 | Southwest Research Institute | System and method for identifying and correcting abnormal oscillometric pulse waves |
US5971930A (en) | 1997-10-17 | 1999-10-26 | Siemens Medical Systems, Inc. | Method and apparatus for removing artifact from physiological signals |
US6099481A (en) | 1997-11-03 | 2000-08-08 | Ntc Technology, Inc. | Respiratory profile parameter determination method and apparatus |
US6155992A (en) | 1997-12-02 | 2000-12-05 | Abbott Laboratories | Method and apparatus for obtaining interstitial fluid for diagnostic tests |
JP3213278B2 (en) | 1998-05-12 | 2001-10-02 | 日本コーリン株式会社 | Non-invasive continuous blood pressure estimation device |
US5997482A (en) | 1998-06-01 | 1999-12-07 | Vaschillo; Evgeny G. | Therapeutic method for a human subject |
US6129675A (en) | 1998-09-11 | 2000-10-10 | Jay; Gregory D. | Device and method for measuring pulsus paradoxus |
US6480733B1 (en) | 1999-11-10 | 2002-11-12 | Pacesetter, Inc. | Method for monitoring heart failure |
-
2002
- 2002-02-22 US US10/081,719 patent/US6702752B2/en not_active Expired - Lifetime
Cited By (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060004405A1 (en) * | 2001-10-18 | 2006-01-05 | Amr Salahieh | Vascular embolic filter devices and methods of use therefor |
US20050209521A1 (en) * | 2002-05-29 | 2005-09-22 | Joni Kettunen | Procedure for deriving reliable information on respiratory activity from heart period measurement |
US7460901B2 (en) * | 2002-05-29 | 2008-12-02 | Firstbeat Technologies Oy | Procedure for deriving reliable information on respiratory activity from heart period measurement |
US20040225207A1 (en) * | 2003-05-09 | 2004-11-11 | Sang-Kon Bae | Ear type apparatus for measuring a bio signal and measuring method therefor |
US7209775B2 (en) * | 2003-05-09 | 2007-04-24 | Samsung Electronics Co., Ltd. | Ear type apparatus for measuring a bio signal and measuring method therefor |
US8343057B2 (en) * | 2003-12-01 | 2013-01-01 | Ric Investments, Llc | Apparatus and method for monitoring pressure related changes in the extra-thoracic arterial circulatory system |
US20100222655A1 (en) * | 2003-12-01 | 2010-09-02 | Ric Investments, Llc | Apparatus and method for monitoring pressure related changes in the extra-thoracic arterial circulatory system |
EP3066978A1 (en) * | 2003-12-30 | 2016-09-14 | Beta Biomed Services, Inc. | Method and system of monitoring respiration in an individual |
US20070021673A1 (en) * | 2004-01-27 | 2007-01-25 | Cardiometer Ltd. | Method and system for cardiovascular system diagnosis |
US20100174200A1 (en) * | 2004-03-18 | 2010-07-08 | Respironics, Inc. | Methods and devices for relieving stress |
US7691049B2 (en) | 2004-03-18 | 2010-04-06 | Respironics, Inc. | Methods and devices for relieving stress |
US8938288B2 (en) * | 2004-03-18 | 2015-01-20 | Respironics, Inc. | Methods and devices for relieving stress |
US8641631B2 (en) | 2004-04-08 | 2014-02-04 | Masimo Corporation | Non-invasive monitoring of respiratory rate, heart rate and apnea |
US7139701B2 (en) | 2004-06-30 | 2006-11-21 | Motorola, Inc. | Method for detecting and attenuating inhalation noise in a communication system |
US7254535B2 (en) | 2004-06-30 | 2007-08-07 | Motorola, Inc. | Method and apparatus for equalizing a speech signal generated within a pressurized air delivery system |
US7155388B2 (en) | 2004-06-30 | 2006-12-26 | Motorola, Inc. | Method and apparatus for characterizing inhalation noise and calculating parameters based on the characterization |
US20060020451A1 (en) * | 2004-06-30 | 2006-01-26 | Kushner William M | Method and apparatus for equalizing a speech signal generated within a pressurized air delivery system |
US20060009970A1 (en) * | 2004-06-30 | 2006-01-12 | Harton Sara M | Method for detecting and attenuating inhalation noise in a communication system |
US20060009971A1 (en) * | 2004-06-30 | 2006-01-12 | Kushner William M | Method and apparatus for characterizing inhalation noise and calculating parameters based on the characterization |
US9668695B2 (en) | 2004-08-11 | 2017-06-06 | University Of Florida Research Foundation, Inc. | Pulse oximeter probes and methods for using the same |
US11259749B2 (en) | 2004-08-11 | 2022-03-01 | Koninklijke Philips N.V. | Pulse oximeter probes and methods for using the same |
US20070056582A1 (en) * | 2005-03-18 | 2007-03-15 | Michael Wood | Methods and devices for relieving stress |
US8002711B2 (en) | 2005-03-18 | 2011-08-23 | Respironics, Inc. | Methods and devices for relieving stress |
US8428702B2 (en) | 2005-03-18 | 2013-04-23 | Respironics, Inc. | Methods and devices for relieving stress |
US7438688B2 (en) | 2005-08-26 | 2008-10-21 | Nihon Kohden Corporation | Apparatus and method for measuring pulse rate |
EP1757225A1 (en) * | 2005-08-26 | 2007-02-28 | Nihon Kohden Corporation | Apparataus and method for measuring pulse rate |
GB2438070A (en) * | 2006-05-12 | 2007-11-14 | Suunto Oy | Determining energy consumption during exercise from respiratory frequency derived from heart rate measurements |
GB2438070B (en) * | 2006-05-12 | 2010-11-17 | Suunto Oy | Method, Device and computer program product for monitoring the physiological state of a person |
US11229374B2 (en) | 2006-12-09 | 2022-01-25 | Masimo Corporation | Plethysmograph variability processor |
US20100004552A1 (en) * | 2006-12-21 | 2010-01-07 | Fresenius Medical Care Deutschland Gmbh | Method and device for the determination of breath frequency |
US7922664B2 (en) * | 2007-04-05 | 2011-04-12 | Coherence Llc | Method and system for improving physiologic status and health via assessment of the dynamic respiratory arterial pressure wave using plethysmographic technique |
US20080249422A1 (en) * | 2007-04-05 | 2008-10-09 | Stephen Bennett Elliott | Method and system for improving physiologic status and health via assessment of the dynamic respiratory arterial pressure wave using plethysmographic technique |
US20100298730A1 (en) * | 2007-07-30 | 2010-11-25 | Oxford Biosignals Limited | Method and apparatus for measuring breathing rate |
US8465434B2 (en) * | 2007-12-06 | 2013-06-18 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Method and system for detection of respiratory variation in plethysmographic oximetry |
US20120172688A1 (en) * | 2007-12-06 | 2012-07-05 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Method and system for detection of respiratory variation in plethysmographic oximetry |
US8398555B2 (en) | 2008-09-10 | 2013-03-19 | Covidien Lp | System and method for detecting ventilatory instability |
US20100106030A1 (en) * | 2008-10-23 | 2010-04-29 | Mason Gregory R | Method and system for automated measurement of pulsus paradoxus |
US8515513B2 (en) | 2008-11-05 | 2013-08-20 | Covidien Lp | System and method for facilitating observation of monitored physiologic data |
US20100113904A1 (en) * | 2008-11-05 | 2010-05-06 | Nellcor Puritan Bennett Llc | System And Method For Facilitating Observation Of Monitored Physiologic Data |
US9351665B2 (en) | 2009-01-14 | 2016-05-31 | Widemed Technologies Ltd. | Method and system for detecting a respiratory signal |
WO2010082200A1 (en) * | 2009-01-14 | 2010-07-22 | Widemed Ltd. | Method and system for detecting a respiratory signal |
US9877686B2 (en) | 2009-10-15 | 2018-01-30 | Masimo Corporation | System for determining confidence in respiratory rate measurements |
US9066680B1 (en) | 2009-10-15 | 2015-06-30 | Masimo Corporation | System for determining confidence in respiratory rate measurements |
US10813598B2 (en) | 2009-10-15 | 2020-10-27 | Masimo Corporation | System and method for monitoring respiratory rate measurements |
US9848800B1 (en) | 2009-10-16 | 2017-12-26 | Masimo Corporation | Respiratory pause detector |
US10595747B2 (en) | 2009-10-16 | 2020-03-24 | Masimo Corporation | Respiration processor |
US9724016B1 (en) | 2009-10-16 | 2017-08-08 | Masimo Corp. | Respiration processor |
US11399722B2 (en) | 2010-03-30 | 2022-08-02 | Masimo Corporation | Plethysmographic respiration rate detection |
US9307928B1 (en) * | 2010-03-30 | 2016-04-12 | Masimo Corporation | Plethysmographic respiration processor |
US10098550B2 (en) | 2010-03-30 | 2018-10-16 | Masimo Corporation | Plethysmographic respiration rate detection |
US9402554B2 (en) | 2011-09-23 | 2016-08-02 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9119597B2 (en) | 2011-09-23 | 2015-09-01 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US8880576B2 (en) | 2011-09-23 | 2014-11-04 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9675274B2 (en) | 2011-09-23 | 2017-06-13 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9737266B2 (en) | 2011-09-23 | 2017-08-22 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9693709B2 (en) | 2011-09-23 | 2017-07-04 | Nellcot Puritan Bennett Ireland | Systems and methods for determining respiration information from a photoplethysmograph |
US9060746B2 (en) | 2011-11-30 | 2015-06-23 | Covidien Lp | Systems and methods for detecting arrhythmia from a physiological signal |
US8755871B2 (en) | 2011-11-30 | 2014-06-17 | Covidien Lp | Systems and methods for detecting arrhythmia from a physiological signal |
US9693736B2 (en) | 2011-11-30 | 2017-07-04 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information using historical distribution |
US9247896B2 (en) | 2012-01-04 | 2016-02-02 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information using phase locked loop |
US10376157B2 (en) | 2012-01-04 | 2019-08-13 | Nellcor Puritan Bennett Ireland | Systems and methods for determining respiration information using phase locked loop |
US11478155B2 (en) | 2012-02-24 | 2022-10-25 | Covidien Lp | Hypovolemia diagnosis technique |
US8880155B2 (en) | 2012-02-24 | 2014-11-04 | Covidien Lp | Hypovolemia diagnosis technique |
US9801579B2 (en) | 2012-03-19 | 2017-10-31 | Fujitsu Limited | Arousal-level determining apparatus and arousal-level determining method |
US9179876B2 (en) | 2012-04-30 | 2015-11-10 | Nellcor Puritan Bennett Ireland | Systems and methods for identifying portions of a physiological signal usable for determining physiological information |
US20140039283A1 (en) * | 2012-07-31 | 2014-02-06 | Periodic Breathing Foundation | System for analyzing oximetry data |
US10631738B2 (en) * | 2012-07-31 | 2020-04-28 | The Periodic Breathing Foundation, Llc | System for analyzing oximetry data |
US9560978B2 (en) | 2013-02-05 | 2017-02-07 | Covidien Lp | Systems and methods for determining respiration information from a physiological signal using amplitude demodulation |
US9687159B2 (en) | 2013-02-27 | 2017-06-27 | Covidien Lp | Systems and methods for determining physiological information by identifying fiducial points in a physiological signal |
US9554712B2 (en) | 2013-02-27 | 2017-01-31 | Covidien Lp | Systems and methods for generating an artificial photoplethysmograph signal |
US10441181B1 (en) | 2013-03-13 | 2019-10-15 | Masimo Corporation | Acoustic pulse and respiration monitoring system |
US10022068B2 (en) | 2013-10-28 | 2018-07-17 | Covidien Lp | Systems and methods for detecting held breath events |
US9848820B2 (en) | 2014-01-07 | 2017-12-26 | Covidien Lp | Apnea analysis system and method |
US10537289B2 (en) | 2014-02-20 | 2020-01-21 | Covidien Lp | Systems and methods for filtering autocorrelation peaks and detecting harmonics |
US9901308B2 (en) | 2014-02-20 | 2018-02-27 | Covidien Lp | Systems and methods for filtering autocorrelation peaks and detecting harmonics |
US20160143566A1 (en) * | 2014-11-20 | 2016-05-26 | Qualcomm Incorporated | Circuitry to Allow Low Current Operation of a Device Capable of Determining a Blood Property |
US9743868B2 (en) * | 2014-11-20 | 2017-08-29 | Qualcomm Incorporated | Circuitry to allow low current operation of a device capable of determining a blood property |
US20190261890A1 (en) * | 2015-06-01 | 2019-08-29 | Pixart Imaging Inc. | Optical respiration rate detection device |
US20230293041A1 (en) * | 2015-06-01 | 2023-09-21 | Pixart Imaging Inc. | Optical respiration rate detection device capable of determining denoising range |
US11701027B2 (en) * | 2015-06-01 | 2023-07-18 | Pixart Imaging Inc. | Optical respiration rate detection device |
US10159842B2 (en) | 2015-08-28 | 2018-12-25 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US10589101B2 (en) | 2015-08-28 | 2020-03-17 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US10856743B2 (en) * | 2015-08-28 | 2020-12-08 | Oslermd, Inc. | Methods and apparatuses for measuring multiple vital signs based on arterial pressure waveforms |
US20170055846A1 (en) * | 2015-08-28 | 2017-03-02 | Oslermd, Inc. | Methods and apparatuses for measuring multiple vital signs based on arterial pressure waveforms |
US20180333102A1 (en) * | 2015-12-01 | 2018-11-22 | Koninklijke Philips N.V. | Device, system and method for determining vital sign information of a subject |
CN106725491A (en) * | 2017-02-16 | 2017-05-31 | 王丽燕 | A kind of respiratory rate method for determining child patient |
US11272859B1 (en) | 2020-08-20 | 2022-03-15 | Cloud Dx, Inc. | System and method of determining respiratory status from oscillometric data |
US11006843B1 (en) | 2020-08-20 | 2021-05-18 | Cloud Dx, Inc. | System and method of determining breathing rates from oscillometric data |
Also Published As
Publication number | Publication date |
---|---|
US6702752B2 (en) | 2004-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6702752B2 (en) | Monitoring respiration based on plethysmographic heart rate signal | |
US6805673B2 (en) | Monitoring mayer wave effects based on a photoplethysmographic signal | |
US6896661B2 (en) | Monitoring physiological parameters based on variations in a photoplethysmographic baseline signal | |
US7001337B2 (en) | Monitoring physiological parameters based on variations in a photoplethysmographic signal | |
US6002952A (en) | Signal processing apparatus and method | |
US10098550B2 (en) | Plethysmographic respiration rate detection | |
US6178343B1 (en) | Pulse rate and heart rate coincidence detection for pulse oximetry | |
US6709402B2 (en) | Apparatus and method for monitoring respiration with a pulse oximeter | |
US20210030372A1 (en) | Methods to estimate the blood pressure and the arterial stiffness based on photoplethysmographic (ppg) signals | |
EP0335357B1 (en) | Improved method and apparatus for detecting optical pulses | |
US6990426B2 (en) | Diagnostic method and apparatus using light | |
US7403806B2 (en) | System for prefiltering a plethysmographic signal | |
US20080167541A1 (en) | Interference Suppression in Spectral Plethysmography | |
US20060293574A1 (en) | Separating oximeter signal components based on color | |
Tanveejul et al. | A Study on the Subject and Location Specificity in Reflectance based SpO 2 Estimation using R-value based Calibration Curve | |
Samimi et al. | Cuffless blood pressure estimation using cardiovascular dynamics | |
KR20060054644A (en) | Method for eliminating motion artifact in pulse oximetry | |
Qananwah et al. | Monitoring Blood Pressure Using Regression Techniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DATEX-OHMEDA, INC., WISCONSIN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DEKKER, ANDREAS LUBBERTUS ALOYSIUS JOHANNES;REEL/FRAME:012959/0187 Effective date: 20020507 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |